% alzhub.org library filter % Source: https://alzhub.org/research?institution=I4405278923 % 7 entries, in the order the page lists them. Built from alzhub.org's own records. % 0 entries have no readable author in the source record and carry no author field. @article{salloway2014-24450891, author = {Salloway, S. and Sperling, R. and Fox, N. C. and Blennow, K. and Klunk, W. and Raskind, M. and Sabbagh, M. and Honig, L. S. and others}, title = {{Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease}}, journal = {The New England journal of medicine}, year = {2014}, doi = {10.1056/nejmoa1304839}, pmid = {24450891}, url = {https://doi.org/10.1056/nejmoa1304839} } @article{liu2015-26208959, author = {Liu, E. and Schmidt, M. E. and Margolin, R. and Sperling, R. and Koeppe, R. and Mason, N. S. and Klunk, W. E. and Mathis, C. A. and others}, title = {{Amyloid-β 11C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials}}, journal = {Neurology}, year = {2015}, doi = {10.1212/wnl.0000000000001877}, pmid = {26208959}, url = {https://doi.org/10.1212/wnl.0000000000001877} } @article{sperling2012-22305802, author = {Sperling, R. and Salloway, S. and Brooks, D. J. and Tampieri, D. and Barakos, J. and Fox, N. C. and Raskind, M. and Sabbagh, M. and others}, title = {{Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis}}, journal = {The Lancet. Neurology}, year = {2012}, doi = {10.1016/s1474-4422(12)70015-7}, pmid = {22305802}, url = {https://doi.org/10.1016/s1474-4422(12)70015-7} } @article{brody2016-27589523, author = {Brody, M. and Liu, E. and Di, J. and Lu, M. and Margolin, R. A. and Werth, J. L. and Booth, K. and Shadman, A. and others}, title = {{A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Safety, Pharmacokinetics, and Biomarker Results of Subcutaneous Bapineuzumab in Patients with mild to moderate Alzheimer's disease}}, journal = {Journal of Alzheimer's disease : JAD}, year = {2016}, doi = {10.3233/jad-160369}, pmid = {27589523}, url = {https://doi.org/10.3233/jad-160369} } @article{ward2013-24174927, author = {Ward, A. and Tardiff, S. and Dye, C. and Arrighi, H. M.}, title = {{Rate of conversion from prodromal Alzheimer's disease to Alzheimer's dementia: a systematic review of the literature}}, journal = {Dementia and geriatric cognitive disorders extra}, year = {2013}, doi = {10.1159/000354370}, pmid = {24174927}, url = {https://doi.org/10.1159/000354370} } @article{sperling2011-21784348, author = {Sperling, Reisa Anne and Jack, Clifford R. and Black, Sandra E. and Frosch, Matthew P. and Greenberg, Steven Mark and Hyman, Bradley T. and Scheltens, Philip and Carrillo, María C. and Thies, William H. and Bednar, Martin M. and Black, Ronald S. and Brashear, H. Robert and Grundman, Michael and Siemers, Eric and Feldman, Howard and Schindler, Rachel J.}, title = {{Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: Recommendations from the Alzheimer’s Association Research Roundtable Workgroup}}, journal = {Alzheimer s \& Dementia}, year = {2011}, doi = {10.1016/j.jalz.2011.05.2351}, pmid = {21784348}, url = {https://doi.org/10.1016/j.jalz.2011.05.2351} } @article{rinne2010-20189881, author = {Rinne, Juha O. and Brooks, David James and Rossor, Martin N. and Fox, Nick C. and Bullock, Roger Alan and Klunk, William E. and Mathis, Chester A. and Blennow, Kaj and Barakos, Jerome A. and Okello, Aren and de Liano, Sofia Rodriguez Martinez and Liu, Enchi and Koller, Martin and Gregg, Keith M. and Schenk, Dale and Black, Ronald S. and Grundman, Michael}, title = {{11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study}}, journal = {The Lancet Neurology}, year = {2010}, doi = {10.1016/s1474-4422(10)70043-0}, pmid = {20189881}, url = {https://doi.org/10.1016/s1474-4422(10)70043-0} }